Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatase receptor type Q (PTPRQ) is a member of the type III receptor-like protein tyrosine phosphatase family, consisting of an extracellular region with multiple fibronectin type III domains, a transmembrane helix, and a cytoplasmic phosphatase domain. It is active against phosphatidylinositol phosphates, with limited activity against phosphotyrosine, and plays crucial roles in regulating cellular survival, proliferation, differentiation, and subcellular architecture. PTPRQ is essential for maturation of cochlear hair bundles, thereby having a critical role in auditory function. Mutations in PTPRQ are linked to both autosomal dominant and recessive hearing loss. Additionally, changes in PTPRQ expression and mutations have been implicated in various cancers, suggesting its broader role in pathology and potential as a therapeutic target. PTPRQ also contributes to adipogenesis by regulating PI3K/AKT signaling through dephosphorylation of PIP3.
Dephosphorylation of phosphatidylinositol phosphates (PIP2/PIP3), Modulation of AKT1 phosphorylation and downstream PI3K/AKT signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase receptor type Q (PTPRQ).